Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a supplemental NADA filed by First Priority, Inc. that provides for revising the description of a 1 g oral dosage form of phenylbutazone from tablet to bolus. To view this final rule, click here.
